-Stephen B Hanauer Researcher Activity Profile

Research Author Detailed Information 

Stephen B Hanauer Publication Rate By Year

Stephen B Hanauer has published 2 paper(s) in 1990, 14 paper(s) in 2007, 15 paper(s) in 2008, for a total of 31 research publications in total.

Stephen B Sb Hanauer Author Information

LAST NAME: hanauer

FIRST NAME: Stephen B

INITIALS: sb

AFFILIATION:

Papers

Stephen B Hanauer's Publication Record

1. Feasibility and utility of an electronic diary to assess self-report symptoms in patients with inflammatory bowel disease. Year Published: 2007
Applied Behavioral Medicine Research Institute, Department of Psychiatry and Behavioral Science, Stony Brook University.
2. Acute and chronic megacolon. Year Published: 2007
Arnold Wald, MD Section of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, 600 Highland Avenue, H6/516 CSC, Madison, WI 53792-5124, USA. axw@medicine.wisc.edu.
3. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Year Published: 2007
University of North Carolina, Chapel Hill, North Carolina 27599-7032, USA. klisaacs@med.unc.edu
4. An ounce of prevention. Year Published: 2007
5. My favorite topic...health. Year Published: 2007
SB Hanauer is Editor-in-Chief of Nature Clinical Practice Gastroenterology & Hepatology.
6. My favorite topic...health. Year Published: 2007
7. An ounce of prevention. Year Published: 2007
8. Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial. Year Published: 2007
University of Chicago School of Medicine, Chicago, USA.
9. Subgroups. Year Published: 2008
10. Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial. Year Published: 2007
11. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Year Published: 2007
Section of Gastroenterology and Nutrition, University of Chicago Medical Center, Chicago, Illinois, USA. miles.sparrow@med.monash.edu.au
12. Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Year Published: 2007
University of North Carolina, Chapel Hill, North Carolina 27599-7032, USA. klisaacs@med.unc.edu
13. My favorite topic...health. Year Published: 2007
14. Treatment of inflammatory bowel disease: A review of medical therapy. Year Published: 2008
Department of Medicine and Clinical Pharmacology, Section of Gastroenterology and Nutrition, 5841 S. Maryland Ave., MC 4076 Chicago, IL 60637, United States. shanauer@uchicago.edu.
15. The benefits of loperamide in the treatment of patients with IBS or IBD. Introduction. Year Published: 2008
Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
16. Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions. Year Published: 2008
Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
17. The role of mesalazine in Crohn's disease. Year Published: 1990
Dept. of Medicine, University of Chicago Medical Center, Illinois 60637.
18. Inflammatory bowel disease revisited: newer drugs. Year Published: 1990
University of Chicago Medical Center, Dept. of Medicine, Illinois 60637.
19. Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial. Year Published: 2007
University of Chicago School of Medicine, Chicago, USA. shanauer@uchicago.edu
20. Semantics. Year Published: 2008
21. Semantics. Year Published: 2008
22. The benefits of loperamide in the treatment of patients with IBS or IBD. Introduction. Year Published: 2008
Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
23. Treatment of diarrhea in patients with inflammatory bowel disease: concepts and cautions. Year Published: 2008
Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
24. Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial. Year Published: 2007
Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. sandborn.william@mayo.edu
25. Treatment of inflammatory bowel disease: a review of medical therapy. Year Published: 2008
Division of Gastroenterology and Hepatology, Department of Medicine, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
26. Biologic therapy for inflammatory bowel disease comes of age. Year Published: 2008
27. Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease. Year Published: 2008
28. Biologic therapy for inflammatory bowel disease comes of age. Year Published: 2008
29. Immunosuppressive therapy in the formation of antibodies to infliximab in Crohn's disease. Year Published: 2008
30. An ounce of prevention. Year Published: 2008
31. What's my beef? Year Published: 2008
SB Hanauer is Editor-in-Chief of Nature Clinical Practice Gastroenterology & Hepatology.